{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:24:19Z","timestamp":1790141059631,"version":"4.0.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejphar.2022.175316","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:57:49Z","timestamp":1665057469000},"page":"175316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-\u03baB pathway"],"prefix":"10.1016","volume":"934","author":[{"given":"Meghna","family":"Bains","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansab","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta Pilkhwal","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175316_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/srep40753","article-title":"Vanillic acid attenuates A\u03b2 1-42-induced oxidative stress and cognitive impairment in mice","volume":"7","author":"Amin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2022.175316_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.biopha.2018.06.020","article-title":"Ellagic acid impedes carbontetrachloride-induced liver damage in rats through suppression of NF-kB, Bcl-2 and regulating Nrf-2 and caspase pathway","volume":"105","author":"Aslan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2022.175316_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.freeradbiomed.2013.04.017","article-title":"Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis","volume":"62","author":"Ayala-Pe\u00f1a","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2022.175316_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-017-3172-0","article-title":"Molecular and biochemical evidence on the protective role of ellagic acid and silybin against oxidative stress-induced cellular aging","volume":"441","author":"Baeeri","year":"2018","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175316_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria","volume":"73","author":"Berman","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2022.175316_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-71779-1_3","article-title":"Mitochondrial dysfunction in huntington's disease","volume":"1049","author":"Carmo","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2022.175316_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175316_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib10","first-page":"1","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"Cruz","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.ejphar.2022.175316_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fct.2018.08.028","article-title":"Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: possible role of PPAR-\u03b3, Bax\/Bcl-2, and caspase-3","volume":"121","author":"Cui","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175316_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib14","first-page":"83","article-title":"Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson's disease","volume":"6","author":"Farbood","year":"2015","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175316_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.toxrep.2018.02.017","article-title":"Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis","volume":"5","author":"Firdaus","year":"2018","journal-title":"Toxicol Rep"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib17","first-page":"306","article-title":"Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: possible neurotransmitters modulation","volume":"69","author":"Gill","year":"2017","journal-title":"Pharmacological Reports. Institute of Pharmacology, Polish Academy of Sciences"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175316_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2022.175316_bib19","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0076-6879(07)00823-3","article-title":"Nitrite and nitrate measurement by griess reagent in human plasma: evaluation of interferences and standardization","author":"Giustarini","year":"2008"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175316_bib20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng0896-442","article-title":"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract","volume":"13","author":"Goldberg","year":"1996","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175316_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12012-018-9446-2","article-title":"Protective effect of ellagic acid against sodium arsenite-induced cardio- and hematotoxicity in rats","volume":"18","author":"Goudarzi","year":"2018","journal-title":"Cardiovasc. Toxicol."},{"issue":"45","key":"10.1016\/j.ejphar.2022.175316_bib23","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo","volume":"30","author":"Graham","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175316_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2022.175316_bib25","series-title":"Antioxidant and Apoptosis-Inducing Activities of Ellagic Acid","author":"Han","year":"2006"},{"issue":"52","key":"10.1016\/j.ejphar.2022.175316_bib26","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","article-title":"In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production","volume":"286","author":"Hands","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington's disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatryarmacology and Biological Psychiatry"},{"key":"10.1016\/j.ejphar.2022.175316_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1017\/S1355617707070671","article-title":"Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches","volume":"13","author":"Hinton","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175316_bib29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-\u03baB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12640-015-9535-y","article-title":"Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism","volume":"28","author":"Jamwal","year":"2015","journal-title":"Neurotox. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175316_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","article-title":"Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington\u2019s Disease-Like Symptoms in Rats","volume":"22","author":"Kalonia","year":"2012","journal-title":"Neurotoxicity Research"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2011.02.037","article-title":"Ellagic acid ameliorates isoproterenol induced oxidative stress: evidence from electrocardiological, biochemical and histological study","volume":"659","author":"Kannan","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175316_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lfs.2018.08.065","article-title":"Memory deficits and hippocampal inflammation in cerebral hypoperfusion and reperfusion in male rats: neuroprotective role of vanillic acid","volume":"211","author":"Khoshnam","year":"2018","journal-title":"Life Sciences. Elsevier Inc"},{"issue":"12","key":"10.1016\/j.ejphar.2022.175316_bib35","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00213-017-4589-6","article-title":"Ellagic acid ameliorates learning and memory deficits in a rat model of Alzheimer's disease: an exploration of underlying mechanisms","volume":"234","author":"Kiasalari","year":"2017","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175316_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/08923973.2010.547500","article-title":"Vanillic acid inhibits inflammatory mediators by suppressing NF-\u03baB in lipopolysaccharide-stimulated mouse peritoneal macrophages","volume":"33","author":"Kim","year":"2011","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2022.175316_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/0076-6879(67)10055-4","article-title":"[52] Preparations and properties of soluble NADH dehydrogenases from cardiac muscle","author":"King","year":"1967","journal-title":"Methods Enzymol."},{"issue":"15","key":"10.1016\/j.ejphar.2022.175316_bib38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.ejphar.2022.175316_bib39","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/121.7.1329","article-title":"Evidence for specific cognitive deficits in preclinical Huntington's disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanism of cellular 3\u2010(4, 5\u2010dimethylthiazol\u20102\u2010yl)\u20102, 5\u2010diphenyltetrazolium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11011-017-0143-9","article-title":"Asiatic acid prevents the quinolinic acid-induced oxidative stress and cognitive impairment","volume":"33","author":"Loganathan","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2022.175316_bib42","series-title":"Methods of Enzymatic Analysis","first-page":"885","article-title":"Catalase","author":"L\u00fcck","year":"1965"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21837","article-title":"Sulforaphane prevents quinolinic acid-induced mitochondrial dysfunction in rat striatum","volume":"31","author":"Luis-Garc\u00eda","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21837","article-title":"Sulforaphane prevents quinolinic acid-induced mitochondrial dysfunction in rat striatum","volume":"31","author":"Luis-Garc\u00eda","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175316_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12893","article-title":"Vanillic acid alleviates palmitic acid\u2010induced oxidative stress in human umbilical vein endothelial cells via Adenosine Monophosphate\u2010Activated Protein Kinase signaling pathway","author":"Ma","year":"2019","journal-title":"J. Food Biochem."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175316_bib46","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3109\/13880209.2015.1137601","article-title":"Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments","volume":"54","author":"Mansouri","year":"2016","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejphar.2022.175316_bib47","first-page":"13","article-title":"Targeting phytochemical driver in AC\/cAMP\/PKA\/CREB activation: the next frontier for alleviating Huntington's type neurodegenerative disorders in 3-NP animal model: a complete review","volume":"6","author":"Mehan","year":"2017","journal-title":"EC Neurol"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0003-9861(77)90509-4","article-title":"Superoxide dismutase: a photochemical augmentation assay","volume":"181","author":"Misra","year":"1977","journal-title":"Arch. Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175316_bib49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-010-0430-7","article-title":"Neuroinflammation in Huntington's disease","volume":"117","author":"M\u00f6ller","year":"2010","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175316_bib50","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.neuropsychologia.2006.01.015","article-title":"Episodic memory impairment in Huntington's disease: a meta-analysis","volume":"44","author":"Montoya","year":"2006","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.ejphar.2022.175316_bib51","series-title":"International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-381328-2.00013-4","article-title":"Huntington's disease: clinical presentation and treatment","author":"Novak","year":"2011"},{"issue":"11","key":"10.1016\/j.ejphar.2022.175316_bib52","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175316_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","article-title":"Microglial priming in neurodegenerative disease","volume":"10","author":"Perry","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175316_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","article-title":"Animal models of Huntington's disease","volume":"48","author":"Ramaswamy","year":"2007","journal-title":"ILAR J."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175316_bib56","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","article-title":"Quinolinic acid is a potent lipid peroxidant in rat brain homogenates","volume":"16","author":"Rios","year":"1991","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-4886(89)90170-2","article-title":"The quinolinic acid model of Huntington's disease: locomotor abnormalities","volume":"105","author":"Sanberg","year":"1989","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175316_bib58","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","article-title":"Body weight and dietary factors in Huntington\u2019s disease patients compared with matched controls","volume":"1","author":"Sanberg","year":"1981","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175316_bib60","first-page":"494","article-title":"Neuroprotective effects of ellagic acid in a rat model of Parkinson's disease","volume":"54","author":"Sarkaki","year":"2016","journal-title":"Acta Med. Iran."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10787-020-00787-3","article-title":"Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-\u03baB mediated neuroinflammatory markers and activation of cAMP\/CREB\/BDNF signaling pathway","volume":"29","author":"Saroj","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"11","key":"10.1016\/j.ejphar.2022.175316_bib62","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","article-title":"3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims","volume":"85","author":"Schwarcz","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2022.175316_bib63","series-title":"Ellagic Acid Prevents 3 - Nitropropionic Acid Induced Symptoms of Huntington \u2019 S Disease\u2019, Naunyn-Schmiedeberg\u2019s Archives of Pharmacology","author":"Sharma","year":"2021"},{"issue":"7","key":"10.1016\/j.ejphar.2022.175316_bib64","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.freeradbiomed.2012.06.008","article-title":"Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.etap.2014.12.008","article-title":"Nephroprotective effect of vanillic acid against cisplatin induced nephrotoxicity in wistar rats: a biochemical and molecular study","volume":"39","author":"Sindhu","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175316_bib66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/13880209.2014.935866","article-title":"Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice","volume":"53","author":"Singh","year":"2015","journal-title":"Pharmaceut. Biol."},{"key":"10.1016\/j.ejphar.2022.175316_bib67","first-page":"1","article-title":"Pathology, prevention and therapeutics of neurodegenerative disease","author":"Singh","year":"2018","journal-title":"Pathology, Prevention and Therapeutics of Neurodegenerative Disease"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib68","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","article-title":"AN electron-transport system Associated with the outer membrane of liver mitochondria: a biochemical and morphological study","volume":"32","author":"Sottocasa","year":"1967","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175316_bib70","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12031-018-1168-1","article-title":"Quinolinic acid-induced huntington disease-like symptoms mitigated by potent free radical scavenger edaravone\u2014a pilot study on neurobehavioral, biochemical, and histological approach in male wistar rats","volume":"66","author":"Sumathi","year":"2018","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175316_bib71","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1039\/C9FO02131K","article-title":"Ellagic acid rescues motor and cognitive deficits in the R6\/2 mouse model of Huntington's disease by lowering mutant huntingtin protein","volume":"11","author":"Sun","year":"2020","journal-title":"Food & Function. Royal Society of Chemistry"},{"issue":"11\u201312","key":"10.1016\/j.ejphar.2022.175316_bib81","first-page":"2061","article-title":"Oxidative damage in Huntington\u2019s disease pathogenesis","volume":"8","author":"Susan","year":"2006","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175316_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175316_bib82","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00001756-199505300-00013","article-title":"Effects of striatal excitotoxicity on Huntingtin-like immunoreactivity","volume":"6","author":"Tatter","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2022.175316_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2018.03.034","article-title":"Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala 2 GIP in rat model of Huntington's disease","volume":"828","author":"Verma","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175316_bib86","first-page":"2767","article-title":"Mechanism of gastrodin in cell apoptosis in rat hippocampus tissue induced by desflurane","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175316_bib77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ejhg.2010.229","article-title":"HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia","volume":"19","author":"Warby","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"18","key":"10.1016\/j.ejphar.2022.175316_bib78","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in huntington's disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175316_bib83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanisms of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175316_bib84","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1742-7843.2007.00129.x","article-title":"Ellagic acid prevents cisplatin\u2010induced oxidative stress in liver and heart tissue of rats","volume":"101","author":"Y\u00fcce","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"24","key":"10.1016\/j.ejphar.2022.175316_bib79","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","article-title":"Huntingtin inhibits caspase-3 activation","volume":"25","author":"Zhang","year":"2006","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175316_bib85","first-page":"4951","article-title":"Ellagic acid ameliorates learning and memory impairment in APP\/PS1 transgenic mice via inhibition of \u03b2\u2011amyloid production and tau hyperphosphorylation","volume":"16","author":"Zhong","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175316_bib80","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1039\/C4FO00384E","article-title":"Inhibition of allergic airway inflammation through the blockage of NF-\u03baB activation by ellagic acid in an ovalbumin-induced mouse asthma model","volume":"5","author":"Zhou","year":"2014","journal-title":"Food Funct."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922005775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922005775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:10:16Z","timestamp":1757977816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922005775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":81,"alternative-id":["S0014299922005775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175316","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175316"}}